A detailed history of American International Group, Inc. transactions in Edgewise Therapeutics, Inc. stock. As of the latest transaction made, American International Group, Inc. holds 28,418 shares of EWTX stock, worth $522,322. This represents 0.0% of its overall portfolio holdings.

Number of Shares
28,418
Previous 21,267 33.62%
Holding current value
$522,322
Previous $232,000 123.28%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$9.25 - $19.97 $66,146 - $142,805
7,151 Added 33.62%
28,418 $518,000
Q4 2023

Feb 13, 2024

SELL
$5.51 - $12.1 $473 - $1,040
-86 Reduced 0.4%
21,267 $232,000
Q3 2023

Nov 13, 2023

BUY
$5.73 - $7.69 $4,349 - $5,836
759 Added 3.69%
21,353 $122,000
Q2 2023

Aug 04, 2023

BUY
$5.71 - $10.29 $13,133 - $23,666
2,300 Added 12.57%
20,594 $159,000
Q1 2023

May 12, 2023

BUY
$6.66 - $11.33 $2,424 - $4,124
364 Added 2.03%
18,294 $122,000
Q4 2022

Feb 10, 2023

BUY
$7.58 - $11.08 $28,932 - $42,292
3,817 Added 27.05%
17,930 $160,000
Q3 2022

Nov 14, 2022

BUY
$8.08 - $13.58 $1,616 - $2,716
200 Added 1.44%
14,113 $139,000
Q2 2022

Aug 12, 2022

SELL
$5.67 - $9.87 $30,033 - $52,281
-5,297 Reduced 27.57%
13,913 $111,000
Q1 2022

May 13, 2022

SELL
$9.1 - $18.97 $12,294 - $25,628
-1,351 Reduced 6.57%
19,210 $186,000
Q4 2021

Feb 11, 2022

BUY
$14.41 - $22.41 $195,514 - $304,058
13,568 Added 194.02%
20,561 $314,000
Q3 2021

Nov 12, 2021

BUY
$14.11 - $24.1 $1,114 - $1,903
79 Added 1.14%
6,993 $116,000
Q2 2021

Aug 13, 2021

BUY
$21.33 - $30.25 $147,475 - $209,148
6,914 New
6,914 $147,000

Others Institutions Holding EWTX

About Edgewise Therapeutics, Inc.


  • Ticker EWTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 63,171,700
  • Market Cap $1.16B
  • Description
  • Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has c...
More about EWTX
Track This Portfolio

Track American International Group, Inc. Portfolio

Follow American International Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.